Inflamed Yet Immune-Evasive? A Transcriptomic Meta-Analysis Identifies Conserved Inflammatory, Developmental, and...

Area of Science:

• Oncology
• Cancer Biology
• Genomics

Background:

• Polyploid giant cancer cells (PGCCs) are linked to therapy resistance and tumor recurrence.
• The molecular mechanisms sustaining PGCCs under therapeutic pressure are not fully understood.

Purpose of the Study:

• To identify conserved gene expression programs in PGCCs across multiple cancer types.
• To elucidate the regulatory architecture that stabilizes the PGCC state during treatment.

Main Methods:

• Integrative transcriptomic analysis of PGCCs from prostate, ovarian, and breast cancers.
• Analysis of eight independent datasets to identify consistently deregulated genes.
• Statistical filtering based on expression consistency, significance, and directionality.

Main Results:

• PGCCs display a paradoxical signature of cytolytic activity and immune evasion.
• They activate pro-inflammatory signaling while employing PD-L1 and viral escape mechanisms.
• Transcriptional features include immune privilege, embryonic/reproductive programs, senescence, apoptosis resistance, dormancy, and neuronal differentiation pathways.
• Activation of neuron-like, calcium-dependent stress adaptation enhances immune privilege and survival.

Conclusions:

• PGCCs establish an immune-adaptive polyploid survival state by repurposing inflammatory and ontogenetic pathways for immune evasion and persistence.
• Vulnerabilities in calcium signaling, neuronal mimicry, and checkpoint pathways offer therapeutic targets.
• Dismantling the PGCC reservoir is crucial for preventing tumor relapse.